Search Weight Loss Topics:


Page 59«..1020..58596061..7080..»


May 25

LL Cool J says he paved the way for Drake to rap about his feelings – NME

LL Cool J has argued that he paved the way for a number of modern rappers who approach certain themes, singling out Drake, Fabolous and Jadakiss.

Discussing his 1987 hit I Need Love, one of the first sensitive hip-hop tracks to become a hit, the rapper remembered a lot of friction when the track was released.

Back then, it was really conservative and if the energy wasnt testosterone, like Im punching you in your face, kicking the door down, you dont get a lot of credit, he told Complex.

In hip hop, you only get brownie points for creativity within certain parameters When you try to go outside of that box, if its anything thats not considered 1000% street, [you get] no credit.

Later in the interview, LL said he was glad that it created a genre, before singling out some of the rappers he believes hes inspired.

Going on to address direct comparisons to Drake, LL said: Were very different artists because I have a lot of hard records and Im very diverse, he continued. But in that aspect of my career, it paved the way for guys like that who Im happy for. I like a lot of his music too.

Drake meanwhile, apologised last week for referring to Kylie Jenner as his side-piece in a track hed released a few days earlier.

See more here:
LL Cool J says he paved the way for Drake to rap about his feelings - NME


May 25

Lance Armstrong Doping: What Kind of Drugs Did He Take? – Heavy.com

GettyLance Armstrong admitted to taking EPO and other drugs during his cycling career.

After years of denial, former cyclist Lance Armstrong admitted to doping during a 2013 interview with Oprah. Armstrong admitted to taking EPO, doping his blood and using other banned substances such as testosterone. The former cyclist described taking a cocktail which included EPO, transfusions and testosterone.

I viewed it as very simple, Armstrong explained to Oprah (via BBC transcript). There were things that were oxygen-supplying drugs that were beneficial for cycling. My cocktail was EPO, but not a lot, transfusions and testosterone. I thought, surely Im running low [on testosterone following the cancer battle] but theres no true justification.

EPO refers to Erythropoietin which is naturally produced by the kidney as the Cleveland Clinic detailed.

Erythropoietin (EPO) is produced by the kidney and used to make red blood cells, the organization explained. Erythropoetin-stimulating agents are used often for people with long-term kidney disease and anemia.

Lance Armstrong Oprah Interview: Doping Confession to Winfrey After Years of DenialAfter years of denying doping allegations, the cyclist came clean about performance-enhancing drugs. For more on this story, click here: http://abcnews.go.com/US/lance-armstrong-confesses-doping/story?id=182440032013-01-18T15:43:09Z

The benefits of taking EPO involved the oxygen that is able to go to the users muscles.

An increase in red blood cells improves the amount of oxygen that the blood can carry to the bodys muscles, the World Anti-Doping Agency explained.

The organization also noted that testing measures have been enhanced. The World Anti-Doping Agency admitted that earlier testing that was introduced in 2000 allowed a large number of EPO abusers to escape detection.

The conservative approach used in the initial phase of implementation of the method allowed a large number of EPO abusers to escape detection.

Consistent with the advancing science in anti-doping, work is done on an ongoing basis on all detection methods to refine their sensitivity and the interpretation of results. In the case of EPO, based on expert consensus, new interpretation criteria are introduced as science advances for a more discriminant reading of EPO results.

Effects of erythropoietin on cycling performance of well-trained cyclistsResults from a double-blind, randomised, placebo-controlled trial. Animation by Folkert van Meurs. Read the Article at: http://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(17)30105-9/abstract Published: June 29, 20172017-07-17T14:28:27Z

Armstrong discusses his decision to dope in detail in the new ESPN documentary LANCE. According to Esquire, the former cyclist referred to EPO as a safe drug during one of his extensive interviews in the documentary.

In many waysand this is not going to be a popular answerEPO is a safe drug, Armstrong noted, per Esquire. Assuming certain things, assuming [it is] taken properly, taken under the guidance of a medical professional, taken in conservative amounts There are far worse things you can put in your body.

Armstrong cited a corrupt culture in the sport during his 2013 interview with Oprah where he finally admitted to wrongdoing. The former cyclist implied that he was not alone in cheating when he was racing and admitted he did not think anyone could win without doping.

Not in that generation, and Im not here to talk about others in that generation, Armstrong noted (via BBC). Its been well-documented. I didnt invent the culture, but I didnt try to stop the culture, and thats my mistake, and thats what I have to be sorry for, and thats what something and the sport is now paying the price because of that. So I am sorry for that. I didnt have access to anything else that nobody else did.

Read the original:
Lance Armstrong Doping: What Kind of Drugs Did He Take? - Heavy.com


May 23

Debi Mazar Channeled Her Entourage Character Whenever Things Got Tough on the Testosterone-Driven Set – KCTV Kansas City

'); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append('"+val.ihtml+""); $("#expandable-weather-block .weather-index-alerts").show(); $("#expandable-weather-block .modal-body h2").css({"font-family":"'Fira Sans', sans-serif", "font-weight":"500", "padding-bottom":"10px"}); $("#expandable-weather-block .modal-body p").css({"font-size":"14px", "line-height":"24px"}); $("#expandable-weather-block .modal-body span.wxalertnum").css({"float":"left", "width":"40px", "height":"40px", "color":"#ffffff", "line-height":"40px", "background-color":"#888888", "border-radius":"40px", "text-align":"center", "margin-right":"12px"}); $("#expandable-weather-block .modal-body b").css("font-size", "18px"); $("#expandable-weather-block .modal-body li").css({"font-size":"14px", "line-height":"18px", "margin-bottom":"10px"}); $("#expandable-weather-block .modal-body ul").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body pre").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body img").css({"width":"100%", "margin-bottom":"20px", "borderWidth":"1px", "border-style":"solid", "border-color":"#aaaaaa"}); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).css({"borderWidth":"0", "border-bottom-width":"1px", "border-style":"dashed", "border-color":"#aaaaaa", "padding-bottom":"10px", "margin-bottom":"40px"}); }); } function parseAlertJSON(json) { console.log(json); alertCount = 0; if (Object.keys(json.alerts).length > 0) { $("#mrd-wx-alerts .modal-body ").empty(); } $.each(json.alerts, function(key, val) { alertCount++; $("#mrd-wx-alerts .alert_count").text(alertCount); $("#mrd-wx-alerts .modal-body ").append(''); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } else if (val.fips != "" && val.fipsimg != "") { // $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } // } //val.instr = val.instr.replace(/[W_]+/g," "); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(val.dhtml+"

Instruction

Follow this link:
Debi Mazar Channeled Her Entourage Character Whenever Things Got Tough on the Testosterone-Driven Set - KCTV Kansas City


May 21

Viewpoint: Time to stop thinking of testosterone as a ‘magic male molecule’ – Genetic Literacy Project

We place unreasonable trust in biological explanations of male behavior. Nowhere is this truer than with testosterone. Contemporary pundits invoke the hormone nicknamed T to prove points about maleness and masculinity, to show how different men and women are, and to explain why some men (presumably those with more T) have greater libidos. Yet, despite the mythic properties popularly associated with T, in every rigorous scientificstudyto date there is no significant correlation in healthy men between levels of T and sexual desire.

Beginning in the 1990s and really picking up steam in the 2000s, sales of testosterone replacement therapies (TRTs) went from practically zero to over $5 billion annually in 2018. This was either because there was a sudden outbreak of Low T when a major medical epidemic was finally recognized, or because T became marketed as a wonder drug for men thrown into a panic when they learned that their T levels declined1 per cent annually after they hit 30.

The answer is not that mens bodies changed or that Low T was horribly underdiagnosed before but that, in the minds of many, T became nothing short of a magic male molecule that could cure men of declining energy and sexual desire as they aged.

Whats more, many have been taught that, if you want to know what causes some men to be aggressive, you just test their T levels, right? Actually, wrong: thesciencedoesnt support this conclusion either. Some of the famous earlystudieslinking T and aggression were conducted on prison populations and were used effectively to prove that higher levels of T were found in some men (read: darker-skinned men), which explained why they were more violent, which explained why they had to be imprisoned in disproportionate numbers. The methodological flaws in these studies took decades to unravel, and new rigorousresearchshowinglittlerelation between T and aggression (except at very high or very low levels) is just now reaching the general public.

Whats more, it turns out that T is not just one thing (a sex hormone) with one purpose (male reproduction). T is also essential in the development of embryos, muscles, female as well as male brains, and red blood cells. Depending on a range of biological, environmental and social factors, its influence is varied or negligible.

Robert Sapolsky, a neuroscientist at Stanford University in California,compileda table showing that there were only 24 scientific articles on T and aggression 1970-80, but there were more than 1,000 in the decade of the 2010s. New discoveries about aggression and T? No, actually, although there were newfindingsin this period showing the importance of T in promotingovulation. There is also a difference between correlation and cause (T levels and aggression, for example, provide a classic chicken-egg challenge). As leading experts on hormones have shown us for years, for the vast majority of men, its impossible to predict who will be aggressive based on their T level, just as if you find an aggressive man (or woman, for that matter), you cant predict their T level.

Testosterone is a molecule that wasmislabeledalmost 100 years ago as a sex hormone, because (some things never change) scientists were looking for definitive biological differences between men and women, and T was supposed to unlock the mysteries of innate masculinity. T is important for mens brains, biceps and that other word for testicles, and it is essential to female bodies. And, for the record, (T level) size doesnt necessarily mean anything:sometimes, the mere presence of T is more important than the quantity of the hormone. Sort of like starting a car, you just need fuel, whether its two gallons or 200. T doesnt always create differences between men and women, or between men. To top it all off, there is evenevidencethat men who report changes after taking T supplements are just as likely reporting placebo effects as anything else.

Still, we continue to imbue T with supernatural powers. In 2018, a US Supreme Court seat hung in the balance. The issues at the confirmation hearings came to focus on male sexual violence against women. Thorough description and analysis were needed. Writers pro and con casually dropped in the T-word to describe, denounce or defend the past behaviour of Justice Brett Kavanaugh: one commentator inForbeswrote about testosterone-induced gang rapes; another, interviewed on CNN, asked: But were talking about a 17-year-old boy in high school with testosterone running high. Tell me, what boy hasnt done this in high school?; and a third, in a column inTheNew York Times, wrote: Thats him riding a wave of testosterone and booze

And it is unlikely that many readers questioned the hormonal logic of Christine Lagarde, then chair of the International Monetary Fund, when she asserted that the economic collapse in 2008 was due in part to too many males in charge of the financial sector: I honestly think that there should never be too much testosterone in one room.

You can find T employed as a biomarker to explain (and sometimes excuse) male behavior in articles and speeches every day. Poetic license, one might say. Just a punchy way to talk about leaving males in charge. Yet when we raise T as significant in any way to explain male behavior, we can inadvertently excuse male behavior as somehow beyond the ability of actual men to control. Casual appeals to biological masculinity imply that patriarchal relationships are rooted in nature.

When we normalize the idea that T runs through all high-school boys, and that this explains why rape occurs, we have crossed from euphemism to offering men impunity to sexually assault women by offering them the defense not guilty, by reason of hormones.

Invoking mens biology to explain their behavior too often ends up absolving their actions. When we bandy about terms such as T or Y chromosomes, it helps to spread the idea that men are controlled by their bodies. Thinking that hormones and genes can explain why boys will be boys lets men off the hook for all manner of sins. If you believe that T says something meaningful about how men act and think, youre fooling yourself. Men behave the way they do because culture allows it, not because biology requires it.

No one could seriously argue that biology is solely responsible for determining what it means to be a man. But words such as testosterone and Y chromosomes slip into our descriptions of mens activities, as if they explain more than they actually do. T doesnt govern mens aggression and sexuality. And its a shame we dont hear as much about theresearchshowing that higher levels of T in men just as easily correlate with generosity as with aggression. But generosity is less a stereotypically male virtue, and this would spoil the story about mens inherent aggressiveness, especially manly mens aggressiveness. And this has a profound impact on what men and women think about mens natural inclinations.

We need to keep talking about toxic masculinity and the patriarchy. Theyre real and theyre pernicious. And we also need new ways of talking about men, maleness and masculinity that get us out of the trap of thinking that mens biology is their destiny. As it turns out, when we sift through the placebo effects and biobabble, T is not a magic male molecule at all but rather as the researchers Rebecca Jordan-Young and Katrina Karkazis argue in theirbookTestosterone(2019) asocialmolecule.

Regardless of what you call it, testosterone is too often used as an excuse for letting men off the hook and justifying male privilege.

Matthew Gutmannis professor of anthropology and faculty fellow at the Watson Institute for International and Public Affairs at Brown University. His latest book isAre Men Animals? How Modern Masculinity Sells Men Short (2019). Follow him on Twitter @MCGutmann

A version of this article was originally published at Aeon and has been republished here with permission. Follow the site on Twitter @aeonmag

Link:
Viewpoint: Time to stop thinking of testosterone as a 'magic male molecule' - Genetic Literacy Project


May 21

Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy – GlobeNewswire

RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead asset, Kyzatrex*. Kyzatrex is an oral Testosterone Replacement Therapy (TRT) that uses an innovative formulation to improve effectiveness and safety.

These allowed claims will provide strong IP protection to December 2030, over 8 years of potential commercial runway. They supplement Marius Pharmaceuticals already robust global patent portfolio for Kyzatrex, which includes granted patents in the European Union, Canada, China, Taiwan, Japan, New Zealand and other key markets, and pending applications in India, and US. Marius Pharmaceuticals patent portfolio includes filings that extend protection to 2033, with the potential to extend protection out to 2040.

The allowed claims protect Kyzatrex, an innovative formulation designed to increase bioavailability and provide a favorable pharmacokinetic (PK) profile compared to other therapeutic alternatives. Om Dhingra, Chief Executive Officer of Marius commented This innovation is truly exceptional as we have created a formulation with a unique PK profile which we believe drives important clinical significance.

Marius Pharmaceuticals Chief Financial Officer Shalin Shah said We are very pleased to strengthen the intellectual property portfolio for Kyzatrex and excited that it has tremendous potential to be differentiated and unique option in the TRT space. We are also drawing a line in the sand between a new treatment paradigm and old testosterone therapies.

Marius Pharmaceuticals has recently completed its pivotal Phase 3 study for Kyzatrex and intends to submit its New Drug Application (NDA) to the Food & Drug Administration (FDA).

About Kyzatrex

Kyzatrex is an experimental therapy for the treatment of primary and secondary hypogonadism (congenital or acquired). Testosterone is a crucial hormone that plays key roles in human growth and development and a wide range of other functions including metabolic and cardiovascular. Sources estimate that 15 million men in the United States suffer from hypogonadism, but only approximately 10% are currently treated. The co-morbidities of men suffering from hypogonadism are also a significant burden on patients and the healthcare system, these include Type 2 Diabetes and other serious chronic conditions.

Current marketed treatments are dominated by painful injections and messy topical applications with transference risk. Kyzatrex is an orally administered therapy, which avoids those drawbacks. Market research points to 93% of patients indicating they would ask their physician about Kyzatrex and more than half would consider a switch from their current regimen.

About Marius Pharmaceuticals

Marius pharmaceuticals is a cutting-edge biopharma company focusing on treating widespread conditions that have been triggered primarily through Androgen deficiency. Our pipeline consists of assets focused on inflammation while our commercial arm is at the forefront of data science technologies core to our commercialization of our lead asset Kyzatrex.

*Kyzatrex is a tentative Tradename currently under review with the FDA

For more information, contact:Shalin Shahshalin@mariuspharma.comwww.mariuspharma.com

Read the original post:
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy - GlobeNewswire


May 21

Women in Charge: Success Against the Coronavirus – The New York Times

To the Editor:

Re Why Are Nations Led by Women Doing Better?, by Amanda Taub (The Interpreter, May 16):

I am glad to see female heads of state getting well-deserved attention for their remarkably successful leadership during the pandemic, but I was disappointed that the womens leadership was characterized as cautious and risk averse in contrast to more aggressive and forward leadership attributed to males. You have it backward.

When others took a cautious wait-and-see stance, women took swift, decisive action to fight the pandemic. They led their countries to go hard, go early, in the powerful phrasing of Prime Minister Jacinda Ardern of New Zealand.

They established aggressive national testing and tracing programs. They communicated forcefully and clearly. And they did all of this at great political risk. Imagine how they would have been pilloried if these costly interventions had been no more successful than the laissez-faire approach of some of their male counterparts.

We must stop stereotyping womens leadership as passive and tentative. In this instance, it was men like Boris Johnson, Donald Trump and Jair Bolsonaro whose leadership was passive, weak or absent.

Monique VanLandinghamSomerset, Va.

To the Editor:

Amanda Taubs article exploring the reasons female leaders are getting better results with the coronavirus pandemic reminded me of what my husband learned when he took his first avalanche safety class: Youre much less likely to die in the backcountry if theres a woman in your group.

Whether its biological (testosterone triggers poorly thought-out decisions that result in death) or social conditioning (men have competitive hubris, women are more comfortable asserting safety concerns), the statistics prove it.

As pointed out in Calamity Lesson, a Jan. 5 article about avalanche fatalities in The New York Times Magazine, All-female groups make better decisions in risky situations than all-male groups or mixed-gender groups.

Given this, and now that weve all seen with our own eyes how testosterone doesnt preclude irrational mood swings and emotional outbursts, I think our country is readier than ever for the steady hand of a reasoned, experienced and capable female vice president. Bring her on. Please.

Madeleine BerensonAvon, Colo.The writer is a ski instructor.

To the Editor:

Amanda Taubs article about the success of women-led countries dealing with Covid-19 leaves out one important factor. The fact that a country elects a woman as its leader speaks to the sensibilities of its people. Draw your own conclusions.

Read this article:
Women in Charge: Success Against the Coronavirus - The New York Times


May 21

Don’t stop sports because of the coronavirus – WFMYNews2.com

After a two-month hiatus, live sports is back on track. At least for NASCAR. Reasons sports are important and should be back even without spectators in the stands.

Sports from the field to the track have been on hold. Until yesterday when NASCAR lit up the track after a two-month hiatus. Even though no spectators were watching from the stands, many fans were cheering in front of TV's or mobile devices. Sports are important to many people because it's an affiliation, an identification, an allegiance to something that you like and believe in. Sports can be addictive in a good way. When your team wins, it's feels like an extension of you. It's the "us" or "we" mentality. For example, "we won"or "we're the champs." And it feels good when your team wins. This good feeling is partly due to the release of dopamine, a feel good hormone. When your team wins, you personally feel like a winner. Research published in the NCBI (National Center for Biotechnology Information) indicated that testosterone levels either increase or decrease based on whether your team wins or loses. The researchers tested testosterone levels through saliva. If you're team wins than you might feel like you're on top of the world. If your team loses then you might feel like you're in the deepest valley.

There are some positives and negatives of not having fans in the stands. The most evident negative is the lack of energy and excitement that fans bring to the games. How many times do you hear about home court advantage? The majority of the fans are the home teams fans. There are couple positives as well. You don't listen to angry fans who yell at their teams' mistakes, yell at the refs or worry about fights between opposing teams' fans. In that respect, there will be some peace.

Even without fans in the stands, starting sports again gives hope that our country is making strides in overcoming the coronavirus pandemic. Sports is part of our lives since childhood, many people have either watched and/or played sports. A lot of lessons are learned from sports such as persistence, sportsmanship, cooperation, leadership, handling winning and losing. Remember that sports without fans cheering in the stands is temporary. Change seems bad until you adapt and see how it'll work out.

More here:
Don't stop sports because of the coronavirus - WFMYNews2.com


May 21

Cover COVID 19: Testosterone Replacement Therapy Market Size Status and Prospect (2020-2026) Mylan,… – Azizsalon News

The Global Testosterone Replacement Therapy Market research report provides an extensive analysis on the industry- and economy-wide database that could potentially offer development strategies and profitability measures to the players in the market. The report includes the trends that are expected to impact the growth of the Testosterone Replacement Therapy Marketduring the forecast period. Evaluation and analysis of these trends are included in the report.

This is the latest report, covering the current COVID-19 impact on the market. The pandemic has affected every aspect of human life globally. This has brought along several changes in the market conditions. The rapidly evolving market scenario and initial and future assessment of the impact are covered in the report. It contains critical information regarding the current and future growth of the market. It focuses on the in-depth analysis of the market. The report has a section dedicated to the profiling of the key companies in the market, along with the market shares they hold.

Our Complimentary Sample Copy In PDF Format for Testosterone Replacement Therapy market Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Get a Free PDF Copy of the Sample Report @https://www.supplydemandmarketresearch.com/home/contact/1092679?ref=Sample-and-Brochure&toccode=SDMRLI1092679

Some prominent companies included in the report are:Endo InternationalAbbVieEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

A highly methodical quantitative as well as qualitative analysis of the global Testosterone Replacement Therapy market has been covered in the report. The study evaluates the numerous aspects of this industry by studying its historical and forecast data. The research report also provides Porters five force model, in tandem with the SWOT analysis and PESTEL analysis of the Testosterone Replacement Therapy market.

By Type:

GelsInjectionsPatchesOthers

By Application:HospitalsClinicsOthers

Further, the research report includes the growth rate of the global Testosterone Replacement Therapy market, tables, facts, figures, and statistics of the key segments.

By Regions:

Grab Your Report at an Impressive Discount! Please click here @https://www.supplydemandmarketresearch.com/home/contact/1092679?ref=Discount&toccode=SDMRLI1092679

Thinking One Step Ahead

In todays competitive world you need to think one step ahead to chase your competitors, our research offers reviews about key players, major collaborations, merger & acquisitions along with trending innovation and business policies to present better insights to drive the business into right direction

Highlights of the Testosterone Replacement Therapy Market Report:

Key Coverage of report:

Read More @https://www.supplydemandmarketresearch.com/global-testosterone-replacement-therapy-market-1092679

Rapid Business Growth Factors

In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor thats helping the market grow faster than usual is the tough competition.

Let us know if you have any specific requirements. We offer report customization.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Original post:
Cover COVID 19: Testosterone Replacement Therapy Market Size Status and Prospect (2020-2026) Mylan,... - Azizsalon News


May 21

Male Hypogonadism Market Future Aspect Analysis and Current Trends by 2017 to 2025 – 3rd Watch News

Global Male Hypogonadism Market: Snapshot

Hypogonadism in males refers to a condition in the male body where the testes show a significantly reduced level of functioning than normal. The overall result of male hypogonadism is a reduction in the rate of biosynthesis of male sex hormones. This state is more commonly known as interrupted stage 1 puberty. Hypoandrogenism, or the low androgen or testosterone level in a male can vary in severity from person to person. It is often the cause of partial or complete infertility. There are multiple forms of male hypogonadism and even more ways to classify them. Most endocrinologists commonly classify male hypogonadism on the basis of the level of defectiveness of the male reproductive system.

In many cases, doctors also measure the level of gonadotropins to classify a patient between primary and secondary male hypogonadism. Primary male hypogonadism refers to the cause of the condition being due to defective gonads. There are different types of primary male hypogonadism, including Turner syndrome and Klinefelter syndrome. Secondary male hypogonadism is caused by defects in pituitary or hypothalamic glands. They include Kallmann syndrome and hypopituitarism.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1127

Global Male Hypogonadism Market: Overview

Male Hypogonadism refers to a clinical condition, wherein the testes fail to produce enough testosterone leading to delayed puberty or incomplete development. The condition is related to impaired development of muscle mass, development of breast tissues, impaired body hair growth, and lack of deepening of the voice.

The male Hypogonadism market can be segmented by therapy, type, drug delivery, and geography.

The report presents an in-depth analysis of the global male hypogonadism market with current trends and future estimates to explain the imminent investment pockets. The quantitative analysis of the market for the forecast period from 2017 to 2025 will enable stakeholders to capitalize on the prevailing growth opportunities.

Global Male Hypogonadism Market: Trends and Opportunities

The top driver of the male hypogonadism market includes rising prevalence of testosterone deficiency among men, increasing infertility rates, and increasing awareness among individuals about hypogonadism treatment due to awareness drives organized by several governments across the world. Moreover, high risk of hypogonadism among the geriatric population with obesity and diabetes, and increasing prevalence of chronic disorders among the geriatrics are further expected to boost the markets growth.

However, factors such as high side effects of testosterone products are challenging the growth of testosterone replacement therapy market. Top players in the market are focused on research and development to introduce newer products with fewer or negligible side effects and improved results. For example, LPCN 1111, a product which is under development from Lipocine Inc., is a newer testosterone prodrug that utilizes Lipral technology for enhanced systemic absorption and for enhanced solubility of testosterone. Nevertheless, technological advancements are anticipated to extend new opportunities to the markets growth.

Global Male Hypogonadism Market: Regional Overview

The global male Hypogonadism market can be analyzed with respect to the regional segments of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America held the majority share of the global market in the recent past and is expected to retain its dominant position in the near future. This is mainly due to the rise in the number of individuals suffering from primary and secondary conditions of hypogonadism, and rising awareness among individuals about treatment options for the condition. Moreover, the presence of ultra-modern healthcare infrastructure and increasing popularity of technologically advanced products are expected to offer new opportunities for top players in this market. The region is closely followed by Europe.

Asia Pacific is expected to offer lucrative opportunities to this market due to the modernization of the healthcare infrastructure in the emerging economies of India and China and the increasing awareness about the treatment for the condition. In Asia Pacific, the increasing prevalence of hypogonadism and infertility rates along with the rising geriatric population base with diabetes and obesity are propelling the growth of this market. China, Taiwan, and Malaysia are some of the countries that display the highest rate of male hypogonadism.

Major Companies Mentioned in Report

Some of the key players in the male Hypogonadism market include AbbVie Inc., Astrazeneca plc, Eli Lilly and Company Ltd., Merck & Co. Inc., SA, Finox Biotech, Laboratories Genevrier, Teva Pharmaceutical Industries Ltd., Allergan plc, Bayer AG, Endo International plc, IBSA Institut Biochimque, and Ferring.

Key players are focused on product approval for growth considerations and to cater to the changing demand of the industry. The introduction of innovative and technologically advanced products is also the focus of key players to increase their market share and for serving patients in a better manner.

Read Comprehensive Overview of Report @https://www.tmrresearch.com/male-hypogonadism-market

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,3739 Balboa St # 1097,San Francisco, CA 94121United StatesTel: +1-415-520-1050

Originally posted here:
Male Hypogonadism Market Future Aspect Analysis and Current Trends by 2017 to 2025 - 3rd Watch News


May 21

Ex-Teacher Who Sexually Abused Students Asks For Castration To Avoid Jail, But Gets 12 Years – Oxygen

A former Florida teacher has been sentenced to 12 years in prison for sexually abusing students with a judge denying his request to be castrated instead of serving time.

Mark Lua, a former English teacher at Booker T. Washington High School in Pensacola, pleaded guilty last year to promoting a sexual performance by a child, unlawful sexual activity with minors and two counts of unlawful sexual activity with minors, according to The Associated Press.

Lua was sentenced Wednesday and told presidingCircuit Judge Thomas Dannheisser he would volunteer for chemical castration if it would spare him a prison sentence and allow him to raise his daughter.

My actions were despicable, Lua said, according to the AP. I do believe that punishment is necessary, and I am requesting chemical castration not only as a punishment but as an act of solidarity to show how sorry I am for everything. If your honor is so inclined, I am even willing to undergo physical castration if that way I can stay home and raise my daughter.

Chemical castration involves the repeated administration of drugs to reduce a person's sex drive and testosterone levels, according to The New York Times. A number of U.S. states have provisions for sex offenders to be chemically castrated under orders from a judge.

Dannheisser ignored the request and sentenced Lua to 12 years in prison,followed by 15 years of probation, according to local outlet the Pensacola News-Journal.

Prosecutors have said Lua preyed on multiple girls: he sexually assaulted an 18-year-old former student and a different underage student, and coercedanother underage studentto send him a sexually explicit video.Theallegations against him resulted in fivecriminal casesbased on the claims of four victims, according to the News-Journal.

Lua had previously admitted to using a fabricated Instagram account to solicit sex from juveniles, according to previous reports. He was fired from the school shortly after authorities charged him in 2019 with multiple sex crimes.

He seemed to seekout girls that came from unstable or troubled homes," Assistant State Attorney Erin Ambrose said in court Wednesday. "He manipulated them, and he betrayed thembecausehe was a teacher.

Crime Time is your destination for true crime stories from around the world, breaking crime news, and information about Oxygen's original true crime shows and documentaries. Sign up for our Crime Time Newsletter and subscribe to our true crime podcast Martinis & Murder for all the best true crime content.

Read the original post:
Ex-Teacher Who Sexually Abused Students Asks For Castration To Avoid Jail, But Gets 12 Years - Oxygen



Page 59«..1020..58596061..7080..»


matomo tracker